158 related articles for article (PubMed ID: 12592360)
1. Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.
Lorusso V; Crucitta E; Silvestris N; Catino A; Caporusso L; Mazzei A; Guida M; Latorre A; Sambiasi D; D'Amico C; Schittulli F; Calabrese P; De Lena M
Br J Cancer; 2003 Feb; 88(4):491-5. PubMed ID: 12592360
[TBL] [Abstract][Full Text] [Related]
2. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
Brugnatelli S; Danova M; De Bella MT; Vaglica M; Manuguerra G; Riccardi A; Palmeri S
Oncology; 2002; 62(1):33-8. PubMed ID: 11810041
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Modi S; Currie VE; Seidman AD; Bach AM; Panageas KS; Theodoulou M; Moasser MM; D'Andrea GM; Lake DE; Choi J; Norton L; Hudis CA
Clin Breast Cancer; 2005 Apr; 6(1):55-60. PubMed ID: 15899073
[TBL] [Abstract][Full Text] [Related]
4. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Ann Oncol; 1999 Feb; 10(2):211-5. PubMed ID: 10093691
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine and mitoxantrone in metastatic breast cancer: a phase-I-study.
Schmid P; Flath B; Akrivakis K; Heilmann V; Mergenthaler HG; Sezer O; Kreienberg R; Possinger K
Invest New Drugs; 2005 Aug; 23(4):349-56. PubMed ID: 16012794
[TBL] [Abstract][Full Text] [Related]
6. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.
Sánchez-Escribano Morcuende R; Alés-Martínez JE; Aramburo González PM
Clin Transl Oncol; 2007 Jul; 9(7):459-64. PubMed ID: 17652060
[TBL] [Abstract][Full Text] [Related]
7. A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients.
Frasci G; D'Aiuto G; Comella P; Thomas R; Capasso I; Botti G; Cortino GR; Di Bonito M; Rubulotta R; Vallone P; Comella G
Oncology; 2002; 62(1):25-32. PubMed ID: 11810040
[TBL] [Abstract][Full Text] [Related]
8. A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N; Kouroussis Ch; Papakotoulas P; Kalbakis K; Tryfonidis K; Vardakis N; Poppis E; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2012 May; 69(5):1345-52. PubMed ID: 22349809
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
Blackstein M; Vogel CL; Ambinder R; Cowan J; Iglesias J; Melemed A
Oncology; 2002; 62(1):2-8. PubMed ID: 11810037
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer.
Kontopodis E; Kentepozidis N; Christophyllakis Ch; Boukovinas I; Kalykaki A; Kalbakis K; Vamvakas L; Agelaki S; Kotsakis A; Vardakis N; Georgoulias V; Mavroudis D
Cancer Chemother Pharmacol; 2015 Jan; 75(1):153-60. PubMed ID: 25398698
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.
Onyenadum A; Gogas H; Kosmidis P; Aravantinos G; Bafaloukos D; Bacoyiannis H; Markopoulos C; Koutras A; Tzorakoelefterakis E; Makatsoris T; Fountzilas G; Kalofonos HP;
J Chemother; 2006 Apr; 18(2):192-8. PubMed ID: 16736889
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
Murad AM
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of trastuzumab plus gemcitabine in chemotherapy-pretreated patients with metastatic breast cancer.
O'Shaughnessy JA; Vukelja S; Marsland T; Kimmel G; Ratnam S; Pippen JE
Clin Breast Cancer; 2004 Jun; 5(2):142-7. PubMed ID: 15245619
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer.
Murad AM; Guimarães RC; Aragão BC; Scalabrini-Neto AO; Rodrigues VH; Garcia R
Am J Clin Oncol; 2001 Jun; 24(3):264-8. PubMed ID: 11404498
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Loesch D; Asmar L; McIntyre K; Doane L; Monticelli M; Paul D; Vukelja S; Orlando M; Vaughn LG; Zhan F; Boehm KA; O'Shaughnessy JA
Clin Breast Cancer; 2008 Apr; 8(2):178-86. PubMed ID: 18621615
[TBL] [Abstract][Full Text] [Related]
16. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Wang T; Zhang S; Zeng M; Lu X; Shen G; Wu S; Song S; Jiang Z
Med Oncol; 2012 Mar; 29(1):56-61. PubMed ID: 21264537
[TBL] [Abstract][Full Text] [Related]
18. Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer.
Iaffaioli RV; Tortoriello A; Santangelo M; Turitto G; Libutti M; Benassai G; Frattolillo A; Ciccarelli PD; De Rosa P; Crovella F; Carbone I; Barbarisi A
Clin Oncol (R Coll Radiol); 2000; 12(4):251-5. PubMed ID: 11005695
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos HP
J Chemother; 2007 Oct; 19(5):582-9. PubMed ID: 18073159
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
Lorusso V; Crucitta E; Panza N; Silvestris N; Guida M; Carpagnano F; Mancarella S; Sambiasi D; De Lena M
Ann Oncol; 2002 Dec; 13(12):1862-7. PubMed ID: 12453853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]